1 / 46

BASHH 2012 UK Re-Audit of Asymptomatic Screening

BASHH 2012 UK Re-Audit of Asymptomatic Screening. Dr Hugo McClean. BASHH 2012 Audit standards. Sexually Transmitted Infections: UK National Screening and Testing Guidelines August 2006 http://www.bashh.org/guidelines Recommended Tests for Asymptomatic Patients

jadon
Download Presentation

BASHH 2012 UK Re-Audit of Asymptomatic Screening

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. BASHH 2012 UK Re-Audit of Asymptomatic Screening Dr Hugo McClean

  2. BASHH 2012 Audit standards • Sexually Transmitted Infections: UK National Screening and Testing Guidelines August 2006 http://www.bashh.org/guidelines • Recommended Tests for AsymptomaticPatients • This presentation builds upon the recommendations from the 2009 audit

  3. BASHH 2012 Audit- presentation scheme • Standards • Methods • Results • Key messages • Recommendations for improvement

  4. Conclusions 2009 Audit • High overall rates of testing with BASHH CEG first line recommended tests for chlamydia, syphilis and HIV • High overall rates of testing for gonorrhoea in women when NAATs included • Important number of cases having N. gonorrhoeae NAATs, including urine GC NAATs (45% MSM) • Urethral microscopy ~ 20% men • Cervical microscopy ~ 10% • Most MSM tested for HepB (80%) • Predominance of hepatitis C testing in MSM

  5. Suggested Areas for Practice Improvement/Interventions 2009 Audit • Increased documentation of discussion about oral and anal sex, as recommended in the BASHH recommendations on sexual history taking to identify which anatomical sites need to be sampled for infection • Regional strategies should be considered to balance nucleic acid amplification testing for gonorrhoea with culture testing to monitor antibiotic sensitivity • Increased screening for hepatitis B in MSM is needed in some regions. • Increased screening for HIV is needed in some regions, particularly for women

  6. Standards

  7. Asymptomatic heterosexual men * Urethral culture only for gonorrhoea: 1194 (58%, 2-98%) ** Recommended if urethral specimen not available

  8. Asymptomatic MSM * Urethral culture only for gonorrhoea ** Recommended if urethral specimen not available

  9. Asymptomatic women * recommended if urethral specimen not available

  10. Case definition • No symptoms offered on presentation (either on a triage form, or similar form, or on direct questioning by a healthcare worker) • Seen during a first meeting in a new or re-book episode

  11. Data collection- 1 • Audit interval: • Clinic policies: on day of audit • Cases seen 1 October to 31 December 2011 • Data collection • Launched 7 Jan 2012 • Closed 15 April 2012 • Participation: • Level 3 services: BASHH NAG Regional Chairs network • BASHH website, emails, BASHH Newsletter

  12. Data collection- 2 • Data submitted using an online form • Clinic policy data • Case note data: • Up to consecutive 40 cases* *RCP Local Clinical Audit: handbook for physicians: http://old.rcplondon.ac.uk/clinical-standards/ceeu/Documents/Local-clinical-audit-handbook-for-physicians-August-2010.pdf

  13. Results • Case, clinic, regional and national level data • National aggregate composed of regional-level data • Percentage of clinics in each BASHH Region meeting performance levels • Overall national performance

  14. Questions asked • Recording of oral sex: occurrence, non-occurrence, patient declined to answer, documented not asked, no record, not applicable • Receptive anal sex: same as for oral sex • Offer of HIV testing: offered & done, offered & declined, not offered, not applicable • Tests for hepatitis B, or immune or chronic infection or not appliacable • Tests for gonorrhoea

  15. Gender and sexual preference • Total 6669 cases • Women: 3321 (50%) • Men: 3348 (50%) • Het men: 3020 (90%) • MSM: 328 (10%)

  16. Number (%) of clinics participating, by Region

  17. Documentation about oral sex

  18. Documentation about receptive oral sex- women 2009: 45% (8-65%) Percentage of cases having a record made about occurrence or non-occurrence of receptive oral sex

  19. Documentation about receptive oral sex- het men Percentage of cases having a record made about occurrence or non-occurrence of receptive oral sex

  20. Documentation about receptive oral sex- MSM 2009: 81% (50-100%) Percentage of cases having a record made about occurrence or non-occurrence of receptive oral sex

  21. Documentation about anal sex

  22. Documentation about receptive anal sex- women Percentage of cases having a record made about occurrence or non-occurrence of receptive anal sex

  23. Documentation about receptive anal sex- MSM Percentage of cases having a record made about occurrence or non-occurrence of receptive anal sex

  24. Recording of occurrence of anal sex in heterosexual men- national data

  25. HIV testing uptake

  26. HIV testing uptake- eligible MSM Percentage of eligible MSM having an HIV test (‘not applicable’ excluded)

  27. HIV testing uptake- eligible women Percentage of eligible women having an HIV test (‘not applicable’ excluded)

  28. HIV testing uptake- eligible het men Percentage of eligible het men having an HIV test (‘not applicable’ excluded)

  29. Hepatitis B testing uptake

  30. Hepatitis B testing uptake- eligible MSM Percentage of eligible MSM having a test for hepatitis B (‘not applicable,’ ‘immune,’ ‘chronic infection ’ all excluded)

  31. Hepatitis B testing uptake- eligible women Percentage of eligible women having a test for hepatitis B (‘not applicable,’ ‘immune,’ ‘chronic infection ’ all excluded)

  32. Hepatitis B testing uptake- eligible het men Percentage of eligible men having a test for hepatitis B (‘not applicable,’ ‘immune,’ ‘chronic infection ’ all excluded)

  33. Gonorrhoea testing

  34. Gonorrhoea testing- MSM, any test done Percentage of MSM having any test done for gonorrhoea

  35. Gonorrhoea testing- women, any test done Percentage of women having any test done for gonorrhoea

  36. Gonorrhoea testing- het men, any test done 2009: 96% (89-100%) Percentage of het men having any test done for gonorrhoea

  37. Gonorrhoea testing- women, tests done (not oropharyngeal NAAT & culture)

  38. Gonorrhoea testing- women, tests done:oropharyngeal & rectal NAAT & culture

  39. 2009 Audit. Asymptomatic women: oropharyngeal & rectal gonorrhoea culture

  40. Gonorrhoea testing- MSM, tests done (not oropharyngeal NAAT & culture)

  41. Gonorrhoea testing- MSM, tests done:oropharyngeal & rectal NAAT & culture

  42. 2009 Audit. Asymptomatic MSM: oropharyngeal & rectal

  43. Gonorrhoea testing- het men, tests done

  44. Key points

  45. Recommendations for improvement • Review policies for gonorrhoea testing, particularly in women, and re-audit interventions aimed at improving uptake of testing • Consensus on sexual history taking questions, reflected in training • Consensus on anatomical site for NAAT testing, reflected in training

  46. Acknowledgements: BASHH Regional Audit Chairs & Members Chair Hugo McCleanVice Chair Chris CarneHon Sec Ann SullivanDirector of Development Anatole Menon-JohanssonBCCG Representative Phil KellBHIVA Representative Alison Rodger, Ed WilkinsScotland Daniel ClutterbuckWales Helen Baley, Sarah McAndrew, Carys KnapperNorthern Ireland Say QuahAnglia Raouf Moussa Cheshire & Mersey Ravindra Gokhale Essex Gail CroweNorth Thames Ann Sullivan, Alan SmithNorthern Sarup TayalNorth-West Ashish SukthankarOxford Gill WildmanSouth East Thames Cindy SethiSouth-West Zoe WarwickSouth-West Thames Steven EstreichTrent Jyoti DharWessex Neelam Radja, Leela SanmaniWest Midlands Sashi AcharyaYorkshire Amy Tobin-Mammen Co-opted Members David Daniels, Nicola Low, Lindsay Emmett Hilary Curtis for questionnaire design, collection, collation of data, user support and production of regional & national aggregates

More Related